SynthesisMedicine2019

The efficacy and safety of neoadjuvant buparlisib for breast cancer: A meta-analysis of randomized controlled studies.

Qian Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.